Comparing Dynamic Parameters of Tumor Vascularization in Nude Mice Revealed by Magnetic Resonance Imaging and Contrast‐Enhanced Intermittent Power Doppler Sonography

Rationale: Angiogenesis is essential for spread and growth of malignant tumors. Because noninvasive methods for observing tumor vascularization are limited, most of previous results were based on histologic findings alone. In this study, dynamic parameters obtained using intermittent contrast‐enhanced Doppler sonography and dynamic MRI were compared and correlated with microvessel density. Methods: Eleven tumor‐bearing nude mice were examined with dynamic T1‐weighted sequences using Gd‐DTPA in a 1.5 T magnetic resonance (MR) scanner and with intermittent power Doppler sonography after a single bolus of galactose based contrast agent. After examination 6 tumors were harvested for immunofluorescence microscopy using a CD31 stain. Using a 2‐compartment model, the MR parameters amplitude (reflecting plasma volume) and kep (influenced by the vessel permeability) were calculated and compared with maximal enhancement (max) and perfusion P measured with ultrasound. Results: The MR amplitude correlated with the ultrasound parameter max significantly (r = 0.61; P = 0.01). Max (r = 0.67; P = 0.01), amplitude (r = 0.72; P = 0.01), and perfusion (r = 0.62; P = 0.05) correlated with the microvessel density. kep moderately correlated with max, but not with perfusion and microvessel density. Conclusions: Dynamic MRI and contrast enhanced ultrasound are supplementing methods for examining perfusion and vascularity of experimental tumors.

[1]  M. Dewhirst,et al.  Magnetic resonance imaging applications in the evaluation of tumor angiogenesis. , 2001, Seminars in radiation oncology.

[2]  G Brix,et al.  Pathophysiologic basis of contrast enhancement in breast tumors , 1999, Journal of magnetic resonance imaging : JMRI.

[3]  S. Fox,et al.  Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs. , 2001, The Lancet. Oncology.

[4]  A R Jayaweera,et al.  Assessment of transmural distribution of myocardial perfusion with contrast echocardiography. , 1998, Circulation.

[5]  J. Minna,et al.  Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice. , 2000, Cancer research.

[6]  Austin Brown.  SI UNITS , 1975, The Lancet.

[7]  J. Garlick,et al.  Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. , 2001, The American journal of pathology.

[8]  M. Bock,et al.  Magnetic Resonance Imaging of Nude Mice With Heterotransplanted High-Grade Squamous Cell Carcinomas: Use of a Low-Loaded, Covalently Bound Gd-Hsa Conjugate as Contrast Agent With High Tumor Affinity , 2002, Investigative radiology.

[9]  M. Neeman,et al.  Neovascularization induced growth of implanted C6 glioma multicellular spheroids: magnetic resonance microimaging. , 1995, Cancer research.

[10]  S. Koscielny,et al.  New hemodynamic approach to angiogenesis: color and pulsed Doppler ultrasonography. , 1999, Investigative radiology.

[11]  G. van Kaick,et al.  Changes of tumor vascularity during gene therapy monitored with color Doppler US. , 2001, Ultrasound in medicine & biology.

[12]  G. Yancopoulos,et al.  Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. , 1999, Science.

[13]  K. Matsumoto,et al.  HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. , 2000, Cancer research.

[14]  R K Jain,et al.  Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. , 1999, Cancer research.

[15]  M. Neeman,et al.  Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging , 1998, Magnetic resonance in medicine.

[16]  P. Tofts.  Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[17]  François Tranquart,et al.  In vivo quantitation of tumour vascularisation assessed by Doppler sonography in rat mammary tumours. , 2002, Ultrasound in medicine & biology.

[18]  W. J. Lorenz,et al.  Pharmacokinetic Mapping of the Breast: A New Method for Dynamic MR Mammography , 1995, Magnetic resonance in medicine.

[19]  G. Seidel,et al.  Evaluation of blood flow in the cerebral microcirculation: analysis of the refill kinetics during ultrasound contrast agent infusion. , 2001, Ultrasound in medicine & biology.

[20]  P. Hauff,et al.  Tumor vascularization in experimental melanomas: correlation between unenhanced and contrast enhanced power Doppler imaging and histological grading. , 2001, Ultrasound in medicine & biology.

[21]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[22]  P. Opolon,et al.  Evaluation of Contrast-Enhanced Color Doppler Ultrasound for the Quantification of Angiogenesis In Vivo , 2001, Investigative radiology.

[23]  Fabian Kiessling,et al.  Comparison of intermittent-bolus contrast imaging with conventional power Doppler sonography: quantification of tumour perfusion in small animals. , 2003, Ultrasound in medicine & biology.

[24]  R. Kerbel.  Tumor angiogenesis: past, present and the near future. , 2000, Carcinogenesis.

[25]  D R Pickens,et al.  Quantified color Doppler sonography of tumor vascularity in an animal model. , 1999, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[26]  S. Baruchel,et al.  Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. , 2000, The Journal of clinical investigation.

[27]  Tejas Mehta,et al.  Use of Doppler ultrasound in the evaluation of breast carcinoma. , 2000, Seminars in ultrasound, CT, and MR.

[28]  S M Evans,et al.  Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations. , 2001, Cancer research.

[29]  P. Agre,et al.  Aquaporins and the respiratory system: advice for a lung investigator. , 2000, The Journal of clinical investigation.

[30]  L. Schad,et al.  Dynamic T1‐weighted monitoring of vascularization in human carcinoma heterotransplants by magnetic resonance imaging , 2003, International journal of cancer.

[31]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[32]  G. van Kaick,et al.  [Imaging the smallest tumor vessels using color Doppler ultrasound in an experiment]. , 2001, Der Radiologe.

[33]  G Brix,et al.  Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. , 1997, Cancer research.

[34]  A R Jayaweera,et al.  Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. , 1998, Circulation.

[35]  Eric R. Ziegel,et al.  A Guide to Statistical Methods and to the Pertinent Literature , 1988 .

[36]  F. Mami-Chouaib,et al.  Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography , 1999, Gene Therapy.

[37]  N. Fusenig,et al.  Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes , 1998, Molecular carcinogenesis.

[38]  Mihaela Skobe,et al.  Halting angiogenesis suppresses carcinoma cell invasion , 1997, Nature Medicine.